| Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis AM Georgoudaki, KE Prokopec, VF Boura, E Hellqvist, S Sohn, J Östling, ... Cell reports 15 (9), 2000-2011, 2016 | 528 | 2016 |
| TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis MF Pang, AM Georgoudaki, L Lambut, J Johansson, V Tabor, K Hagikura, ... Oncogene 35 (6), 748-760, 2016 | 317 | 2016 |
| Synergistic induction of adaptive antitumor immunity by codelivery of antigen with α-galactosylceramide on exosomes U Gehrmann, S Hiltbrunner, AM Georgoudaki, MC Karlsson, TI Näslund, ... Cancer research 73 (13), 3865-3876, 2013 | 136 | 2013 |
| BAFF-secreting neutrophils drive plasma cell responses during emergency granulopoiesis R Parsa, H Lund, AM Georgoudaki, XM Zhang, A Ortlieb Guerreiro-Cacais, ... Journal of Experimental Medicine 213 (8), 1537-1553, 2016 | 87 | 2016 |
| Heterogeneous expression of the adhesion receptor CD226 on murine NK and T cells and its function in NK-mediated killing of immature dendritic cells S Seth, AM Georgoudaki, BJ Chambers, Q Qiu, E Kremmer, MK Maier, ... Journal of leukocyte biology 86 (1), 91-101, 2009 | 64 | 2009 |
| Boosting natural killer cell-mediated targeting of sarcoma through DNAM-1 and NKG2D EC Sayitoglu, AM Georgoudaki, M Chrobok, D Ozkazanc, BJ Josey, M Arif, ... Frontiers in immunology 11, 40, 2020 | 48 | 2020 |
| Natural killer cells in clinical development as non-engineered, engineered, and combination therapies N Lamers-Kok, D Panella, AM Georgoudaki, H Liu, D Özkazanc, ... Journal of Hematology & Oncology 15 (1), 164, 2022 | 44 | 2022 |
| Successive crystal structure snapshots suggest the basis for MHC class I peptide loading and editing by tapasin I Hafstrand, EC Sayitoglu, A Apavaloaei, BJ Josey, R Sun, X Han, ... Proceedings of the National Academy of Sciences 116 (11), 5055-5060, 2019 | 44 | 2019 |
| Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer A Parlar, EC Sayitoglu, D Ozkazanc, AM Georgoudaki, C Pamukcu, ... European journal of immunology 49 (8), 1278-1290, 2019 | 38 | 2019 |
| AIRE expressing marginal zone dendritic cells balances adaptive immunity and T-follicular helper cell recruitment E Lindmark, Y Chen, AM Georgoudaki, D Dudziak, E Lindh, WC Adams, ... Journal of autoimmunity 42, 62-70, 2013 | 38 | 2013 |
| CD244 is expressed on dendritic cells and regulates their functions AM Georgoudaki, S Khodabandeh, S Puiac, CM Persson, MK Larsson, ... Immunology and cell biology 93 (6), 581-590, 2015 | 27 | 2015 |
| Adoptive NK cell therapy: a promising treatment prospect for metastatic melanoma AA van Vliet, AM Georgoudaki, M Raimo, TD de Gruijl, J Spanholtz Cancers 13 (18), 4722, 2021 | 23 | 2021 |
| Cutting edge: Marginal zone macrophages regulate antigen transport by B cells to the follicle in the spleen via CD21 KE Prokopec, AM Georgoudaki, S Sohn, F Wermeling, H Grönlund, ... The Journal of Immunology 197 (6), 2063-2068, 2016 | 20 | 2016 |
| Sensitivity of dendritic cells to NK-mediated lysis depends on the inflammatory environment and is modulated by CD54/CD226-driven interactions LE Smith, MA Olszewski, AM Georgoudaki, AK Wagner, T Hägglöf, ... Journal of Leucocyte Biology 100 (4), 781-789, 2016 | 18 | 2016 |
| Sarcoma tumor microenvironment P Tsagozis, J Gonzalez-Molina, AM Georgoudaki, K Lehti, J Carlson, ... Tumor Microenvironments in Organs: From the Brain to the Skin–Part B, 319-348, 2020 | 9 | 2020 |
| ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma N Mensali, H Köksal, S Joaquina, P Wernhoff, NP Casey, P Romecin, ... Nature Communications 14 (1), 3375, 2023 | 8 | 2023 |
| Reprogramming tumor-associated macrophages by antibody targeting inhibits cancer progression and metastasis. Cell Rep 15: 2000–2011 AM Georgoudaki, KE Prokopec, VF Boura, E Hellqvist, S Sohn, J Ostling, ... | 8 | 2016 |
| Boosting natural killer cell therapies in glioblastoma multiforme using supramolecular cationic inhibitors of heat shock protein 90 T Saha, AA van Vliet, C Cui, JJ Macias, A Kulkarni, LN Pham, S Lawler, ... Frontiers in Molecular Biosciences 8, 754443, 2021 | 6 | 2021 |
| Suicide gene therapy for graft-versus-host disease AM Georgoudaki, T Sutlu, E Alici Immunotherapy 2 (4), 521-537, 2010 | 6 | 2010 |
| Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34+ progenitor cell-derived NK cells AA van Vliet, E Peters, D Vodegel, D Steenmans, M Raimo, S Gibbs, ... Iscience 26 (7), 2023 | 1 | 2023 |
